China Medical System Holdings Limited (OTCMKTS:CHSYF – Get Free Report) shot up 75.6% during mid-day trading on Friday . The company traded as high as $1.64 and last traded at $1.64. 2,800 shares traded hands during mid-day trading, an increase of 282% from the average session volume of 733 shares. The stock had previously closed at $0.93.
China Medical System Price Performance
The stock’s 50 day moving average price is $0.94 and its 200-day moving average price is $0.94.
China Medical System Company Profile
China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company's products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating mild-to-moderate depression, anxiety, and psychosomatic affections; Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis; Salofalk for treating Ulcerative Colitis and Crohn's disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar.
Featured Articles
- Five stocks we like better than China Medical System
- NYSE Stocks Give Investors a Variety of Quality Options
- Why Pure Storage Is a Core Investment for the AI Era
- What does consumer price index measure?
- 2025: A Pivotal Year for Smart Glasses As Meta Invests in Ray-Ban
- What is MarketRank™? How to Use it
- Unity’s New Ad Solutions Drive Stock to 52-Week High
Receive News & Ratings for China Medical System Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Medical System and related companies with MarketBeat.com's FREE daily email newsletter.
